文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停接受目标温度管理患者脑脊液与血清中咪达唑仑及白蛋白浓度的时间关系

Time-course relationship between cerebrospinal fluid and serum concentrations of midazolam and albumin in patients with cardiac arrest undergoing targeted temperature management.
PubMed 文献 · Resuscitation · 2023-06-09
一句话结论心脏骤停后目标温度管理患者脑脊液中咪达唑仑与白蛋白浓度均于复苏后24小时达峰,预后不良组脑脊液/血清比值显著更高且两者正相关,提示复苏后24小时血脑屏障破坏。

本研究为前瞻性、单中心、观察性研究,2020年5月至2022年4月纳入19例心脏骤停后接受目标温度管理的患者,在自主循环恢复后0、24、48、72小时定量脑脊液与血清中咪达唑仑及白蛋白浓度,比较神经功能预后良好组(CPC 1和2)与不良组(CPC 3、4和5)。19例中13例预后不良;0小时血清咪达唑仑浓度最低而血清白蛋白最高,脑脊液中两者浓度均于24小时达峰;两组间脑脊液或血清咪达唑仑浓度无显著差异;咪达唑仑与白蛋白的脑脊液/血清比值在两组间显著不同,且两者比值呈中至强正相关。作者认为这提示心脏骤停后24小时存在血脑屏障破坏。

要点

  • 19例心脏骤停后接受目标温度管理患者中,13例神经功能预后不良(CPC 3、4、5)。
  • 脑脊液中咪达唑仑与白蛋白浓度均于自主循环恢复后24小时达峰。
  • 0小时血清咪达唑仑浓度最低、血清白蛋白水平最高。
  • 两组间脑脊液或血清咪达唑仑浓度无显著差异,但咪达唑仑与白蛋白的脑脊液/血清比值在两组间显著不同。
  • 咪达唑仑与白蛋白的脑脊液/血清比值呈中至强正相关,作者认为提示心脏骤停后24小时血脑屏障破坏。

适用人群与场景

  • 接受目标温度管理的心脏骤停患者,前瞻性观察于2020年5月至2022年4月单中心纳入,共19例。

诊断标准与关键阈值

  • 神经功能预后按脑功能表现分级(CPC)分组:预后良好为CPC 1和2,预后不良为CPC 3、4和5。
  • 在自主循环恢复后0、24、48、72小时定量脑脊液与血清中咪达唑仑及白蛋白浓度。

研究设计与关键结果

  • 研究类型为前瞻性、单中心、观察性研究,纳入19例心脏骤停后接受目标温度管理的患者,其中13例预后不良。
  • 0小时血清咪达唑仑浓度最低、血清白蛋白水平最高;脑脊液中咪达唑仑与白蛋白浓度均于24小时达峰。
  • 预后良好组与不良组之间,脑脊液或血清咪达唑仑浓度无显著差异。
  • 咪达唑仑与白蛋白的脑脊液/血清比值在预后良好组与不良组之间显著不同,不良组显著更高。
  • 咪达唑仑与白蛋白的脑脊液/血清比值之间呈中至强正相关。

证据类型、等级与局限

  • 证据类型:前瞻性、单中心、观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,预后不良组咪达唑仑与白蛋白的脑脊液/血清比值显著更高且两者正相关,提示心脏骤停后24小时血脑屏障破坏。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To understand the serum and cerebrospinal fluid (CSF) distribution of midazolam is important for proper timing of neurological prognostication of targeted temperature management(TTM) patients. Midazolam binds extensively to albumin in serum although non protein bound form exist in CSF. We investigated the time-course of CSF, serum concentrations of midazolam and albumin in patients with cardiac arrest who underwent TTM.

METHODS: This prospective, single-center, observational study was conducted between May 2020 and April 2022. Midazolam and albumin concentrations in CSF and serum were quantified 0, 24, 48, and 72 h after the return of spontaneous circulation for comparison between the good (Cerebral Performance Category (CPC) 1 and 2) and poor (CPC 3, 4, and 5) neurologic outcome groups. The CSF/serum (C/S) ratios of midazolam and albumin concentrations were determined, along with their correlation coefficients.

RESULTS: Of the 19 enrolled patients, 13 experienced poor outcomes. At 0 h, serum midazolam concentrations were the lowest, whereas serum albumin levels were the highest; in the CSF, the concentrations of both peaked at 24 h. There were no significant inter-group differences in midazolam concentrations in CSF or serum. The C/S ratios of midazolam and albumin significantly differed between the groups. Moderate to strong positive correlations were observed between the midazolam and albumin C/S ratios.

CONCLUSION: In CSF, midazolam and albumin concentrations peaked 24 h post-cardiac arrest. Midazolam and albumin C/S ratios were significantly higher in the poor outcome group and positively correlated with each other, suggesting blood-brain barrier disruption 24 h post-cardiac arrest.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Park JI, Kang C, Jeong W, et al. Time-course relationship between cerebrospinal fluid and serum concentrations of midazolam and albumin in patients with cardiac arrest undergoing targeted temperature management. Resuscitation. 2023. PMID: 37302686. doi:10.1016/j.resuscitation.2023.109867

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。